Free Trial
LON:HVO

hVIVO (HVO) Share Price, News & Analysis

hVIVO logo
GBX 10 +0.25 (+2.56%)
As of 11:50 AM Eastern

About hVIVO Stock (LON:HVO)

Key Stats

Today's Range
9.50
10.20
50-Day Range
8.70
18
52-Week Range
6.50
30.50
Volume
932,438 shs
Average Volume
3.23 million shs
Market Capitalization
£70.76 million
P/E Ratio
4.12
Dividend Yield
1.10%
Price Target
GBX 35
Consensus Rating
Buy

Company Overview

hVIVO Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

HVO MarketRank™: 

hVIVO scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    hVIVO has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    hVIVO has only been the subject of 1 research reports in the past 90 days.

  • Read more about hVIVO's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of hVIVO is 4.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.97.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of hVIVO is 4.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.07.

  • Price to Book Value per Share Ratio

    hVIVO has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for HVO.
  • Dividend Yield

    hVIVO pays a meaningful dividend of 1.10%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    hVIVO does not have a long track record of dividend growth.

  • Read more about hVIVO's dividend.
  • Short Interest

    There is no current short interest data available for HVO.
  • News Sentiment

    hVIVO has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.06 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for hVIVO this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, hVIVO insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.03% of the stock of hVIVO is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 34.90% of the stock of hVIVO is held by institutions.

  • Read more about hVIVO's insider trading history.
Receive HVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for hVIVO and its competitors with MarketBeat's FREE daily newsletter.

HVO Stock News Headlines

[Shocking New Report] U.S. Dollar To Crash?
The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…
hVIVO announces annual report and upcoming AGM
See More Headlines

HVO Stock Analysis - Frequently Asked Questions

hVIVO's stock was trading at GBX 20.50 at the start of the year. Since then, HVO shares have decreased by 51.2% and is now trading at GBX 10.

hVIVO plc (LON:HVO) posted its earnings results on Thursday, April, 10th. The company reported $1.69 earnings per share (EPS) for the quarter. hVIVO had a net margin of 25.96% and a trailing twelve-month return on equity of 47.93%.

Shares of HVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that hVIVO investors own include ValiRx (VAL), boohoo group (BOO), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), IQE (IQE) and Rolls-Royce Holdings plc (RR).

Company Calendar

Last Earnings
4/10/2025
Today
7/25/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:HVO
Previous Symbol
LON:RVG
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 35
Low Price Target
GBX 35
Potential Upside/Downside
+250.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX 2.42
Trailing P/E Ratio
4.12
Forward P/E Ratio
6.45
P/E Growth
N/A
Net Income
£17.84 million
Net Margins
25.96%
Pretax Margin
N/A
Return on Equity
47.93%
Return on Assets
11.97%

Debt

Debt-to-Equity Ratio
33.86
Current Ratio
1.61
Quick Ratio
1.16

Sales & Book Value

Annual Sales
£68.74 million
Price / Sales
1.03
Cash Flow
GBX 2.03 per share
Price / Cash Flow
4.94
Book Value
GBX 5.56 per share
Price / Book
1.80

Miscellaneous

Outstanding Shares
707,586,880
Free Float
N/A
Market Cap
£70.76 million
Optionable
Not Optionable
Beta
0.97
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:HVO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners